Cardiovascular disease (CVD) is the leading cause of death worldwide. A search for more
effective treatments of CVD is increasingly needed. Major advances in nanotechnology …

Cardiovascular diseases (CVDs) are the most prominent cause of disability and mortality in
the world. Although there have been a variety of therapeutic options for the management of …

With the advent of nanotechnology, the use and applications of silver nanoparticles (AgNPs)
have increased, both in consumer products as well as in medical devices. However, little is …

Although originally applied in the field of oncology, recent results have illustrated the
considerable potential of gold nanoparticles (GNPs) in the imaging of cardiovascular …

The article overviews the potential biomedical applications of nanoscale gold particles for
predictive, preventive and personalised nanomedicine in cardiology. The review …

Metal nanoparticles (NPs) have garnered considerable attention, due to their unique
physicochemical properties, that render them promising candidates for various applications …

In recent years, an increasing rate of mortality due to myocardial infarction (MI) has led to the
development of nanobased platforms, especially gold nanoparticles (AuNPs), as promising …

Silver nanoparticles (AgNPs) are used in the medical, pharmaceutical and food industry.
Adverse effects and toxicity induced by AgNPs upon cardiac function related to nitric oxide …

Silver nanoparticles (AgNPs) are today one of the most commonly used nanomaterials both
in fundamental medical sciences and clinical practice. These nanoparticles are also …

Recent advances in the synthesis of metal nanoparticles (NPs) have led to tremendous
expansion of their potential applications in different fields, ranging from healthcare research …